Want to see FR:SIGHT full AI Analyst Report?

GenSight Biologics SA (SIGHT) Cash flow

3 Followers

GenSight Biologics SA Cash Flow

FR:SIGHT's free cash flow for Q2 2026 was €-1.80M. For the 2026 fiscal year, FR:SIGHT's free cash flow was decreased by €3.56M and operating cash flow was €-1.73M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	€ -9.38M	€ -12.94M	€ -24.66M	€ -33.75M	€ -17.14M
Investing Cash Flow	€ 180.00K	€ 17.00K	€ 209.00K	€ 172.00K	€ -16.00K
Financing Cash Flow	€ 9.14M	€ 13.54M	€ 15.86M	€ 95.00K	€ 23.74M
End Cash Position	€ 2.42M	€ 2.46M	€ 2.13M	€ 10.61M	€ 44.29M
Free Cash Flow	€ -9.38M	€ -12.94M	€ -24.67M	€ -34.01M	€ -17.17M

Currency in EUR